Literature DB >> 11214097

Effects of itraconazole and terbinafine on Leishmania major lesions in BALB/c mice.

H A Zakai1, S K Zimmo.   

Abstract

The effects of two antifungal compounds, the azole itraconazole and the allylamine terbinafine, on Leishmania major infections in mice are reported. Sixty BALB/c mice were each inoculated subcutaneously with metacyclic promastigotes of L. major at the base of the tail. From 4 weeks post-inoculation, 40 of the mice were treated for 4 weeks (20 with itraconazole and 20 with terbinafine) and the rest were left untreated. Lesion sizes were estimated weekly for 10 weeks post-infection. Both drugs appeared effective in treating the cutaneous lesions but response to itraconazole was faster and, at the end of the experiment, the mean size of the lesions on the mice treated with itraconazole was smaller than that of the lesions on the terbinafine-treated mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11214097     DOI: 10.1080/00034980020027979

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  10 in total

1.  Use of terbinafine in mouse and rat models of Pneumocystis carinii pneumonia.

Authors:  Peter D Walzer; Alan Ashbaugh
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Evaluation of the Efficacy of Amphotericin B and Terbinafine Microemulsions and Their Combination on Cutaneous Leishmaniasis and Comparison with the Conventional Drug Form in BALB/c Mice.

Authors:  Zeynab Baharvandi; Anayatollah Salimi; Reza Arjmand; Ali Jelowdar; Abdollah Rafiei
Journal:  AAPS PharmSciTech       Date:  2022-10-14       Impact factor: 4.026

3.  Host cholesterol influences the activity of sterol biosynthesis inhibitors in Leishmania amazonensis.

Authors:  Valter Viana Andrade-Neto; Pedro Paulo de Abreu Manso; Miria Gomes Pereira; Nuccia Nicole Theodoro de Cicco; Georgia Corrêa Atella; Marcelo Pelajo-Machado; Rubem Figueiredo Sadok Menna-Barreto; Eduardo Caio Torres-Santos
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-04-04       Impact factor: 2.743

4.  Comparison between Combination Therapy of Oral Terbinafine and Cryotherapy versus Systemic Meglumine Antimoniate and Cryotherapy in Cutaneous Leishmaniasis: A Randomized Clinical Trial.

Authors:  Saeedeh Farajzadeh; Iraj Esfandiarpour; Ali Akbar Haghdoost; Saman Mohammadi; Azadeh Mohebbi; Elham Mohebbi; Mahshid Mostafavi
Journal:  Iran J Parasitol       Date:  2015 Jan-Mar       Impact factor: 1.012

5.  Sterol biosynthesis is required for heat resistance but not extracellular survival in leishmania.

Authors:  Wei Xu; Fong-Fu Hsu; Eda Baykal; Juyang Huang; Kai Zhang
Journal:  PLoS Pathog       Date:  2014-10-23       Impact factor: 6.823

6.  Taurine improves the wound healing process in cutaneous leishmaniasis in mice model, based on stereological parameters.

Authors:  Soheil Ashkani-Esfahani; Fariba Zarifi; Qasem Asgari; Asal Zargari Samadnejad; Shima Rafiee; Ali Noorafshan
Journal:  Adv Biomed Res       Date:  2014-10-07

7.  In Vitro and In Vivo Control of Secondary Bacterial Infection Caused by Leishmania major.

Authors:  Hany M Yehia; Ebtesam M Al-Olayan; Manal F El-Khadragy; Dina M Metwally
Journal:  Int J Environ Res Public Health       Date:  2017-07-13       Impact factor: 3.390

Review 8.  Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art.

Authors:  Rebecca L Charlton; Bartira Rossi-Bergmann; Paul W Denny; Patrick G Steel
Journal:  Parasitology       Date:  2017-08-14       Impact factor: 3.234

Review 9.  Cutaneous Leishmaniasis in Saudi Arabia: A Comprehensive Overview.

Authors:  Abuzaid A Abuzaid; Abdalmohsin M Abdoon; Mohamed A Aldahan; Abdullah G Alzahrani; Raaft F Alhakeem; Abdullah M Asiri; Mohamed H Alzahrani; Ziad A Memish
Journal:  Vector Borne Zoonotic Dis       Date:  2017-08-14       Impact factor: 2.133

Review 10.  Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review.

Authors:  Rajamanthrilage Kasun Madusanka; Hermali Silva; Nadira D Karunaweera
Journal:  Infect Dis Ther       Date:  2022-02-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.